|
HS Code |
690854 |
| Generic Name | Ubrogepant |
| Brand Name | Ubrelvy |
| Drug Class | CGRP receptor antagonist |
| Indication | Acute treatment of migraine with or without aura |
| Route Of Administration | Oral |
| Dosage Form | Tablet |
| Approval Status | FDA approved |
| Mechanism Of Action | Blocks the calcitonin gene-related peptide (CGRP) receptor |
| Common Side Effects | Nausea, somnolence, dry mouth |
| Contraindications | Severe hepatic impairment |
As an accredited Ubrogepant factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A white rectangular box labeled "Ubrogepant Tablets 50 mg," containing 30 film-coated tablets in blister packs, with dosage instructions. |
| Storage | Ubrogepant should be stored at room temperature, typically between 20°C to 25°C (68°F to 77°F), away from excessive heat, moisture, and direct light. It should remain in its original container with the lid tightly closed to protect from air and contamination. Keep out of reach of children and do not store in the bathroom or areas with high humidity. |
| Shipping | Ubrogepant is shipped in secure, tightly sealed containers compliant with regulatory guidelines for pharmaceutical substances. Packaging ensures protection from moisture and light, maintaining product stability. Shipments include proper labeling with hazard information, batch numbers, and storage instructions, following both national and international transport regulations for safe and efficient delivery. |
Competitive Ubrogepant prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@p-toluenesulfonicacid-ptbba.com.
We will respond to you as soon as possible.
Tel: +8615371019725
